跳到正文
原文
Nature 健康护理主题·· 16 天前AI 评分40

个性化辅助噬菌体疗法治疗难治性骨科感染

Personalized adjunctive phage therapy for difficult-to-treat musculoskeletal infections

AI 导读

该研究开发了一种个性化辅助噬菌体疗法,用于治疗难治性骨科感染。研究团队从多个机构获得了噬菌体,并在KU Leuven获得了资助。该疗法在动物模型中显示出初步疗效,但仍需进一步临床验证。

正文

Acknowledgements

The authors thank Charlotte Natens for her support during manuscript preparation. Phages were obtained through the Queen Astrid Military Hospital. We acknowledge Inteliphage (BE) for providing access to bacteriophage STA 2780 used in this study. We also thank the Eliava Institute of Bacteriophages, Microbiology and Virology (GE) for providing the bacteriophages ISP, PNM, PT07, and AME-PY. We also acknowledge Ronen Hazan from the Israeli Phage Therapy Center (IPTC) for providing access to the bacteriophage EfGrKN used in this study.

Funding

This study was funded by the KU Leuven Interdisciplinary Networks ID-N grant IDN/20/024/55946278. The funding source had no role in the study design, data collection, data analysis, data interpretation, manuscript preparation, or the decision to submit the manuscript for publication.

Author information

Author notes

  1. These authors contributed equally: Laura Bessems, Louise Sykora.

  2. These authors jointly supervised this work: Jolien Onsea, Willem-Jan Metsemakers.

Authors and Affiliations

  1. Department of Development and Regeneration, KU Leuven, Leuven, Belgium

    Laura Bessems, Louise Sykora, Jolien Onsea & Willem-Jan Metsemakers

  2. Department of Orthopaedic and Trauma Surgery, University Hospitals Leuven, Leuven, Belgium

    Laura Bessems, Louise Sykora, Georges Vles, Hazem Wafa, Jolien Onsea & Willem-Jan Metsemakers

  3. Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium

    Melissa Depypere

  4. Laboratory of Clinical Microbiology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium

    Melissa Depypere & Liesbet Henckaerts

  5. Department of Intensive Care Medicine, University Hospitals Leuven, Leuven, Belgium

    Yves Debaveye

  6. Pharmacy Department, University Hospitals Leuven, Leuven, Belgium

    Isabel Spriet & David Devolder

  7. Department of Pharmaceutical and Pharmacological Sciences, Clinical Pharmacology and Pharmacotherapy, KU Leuven, Leuven, Belgium

    Isabel Spriet

  8. Laboratory for Clinical Infectious and Inflammatory Disorders, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium

    Paul De Munter

  9. Department of General Internal Medicine, University Hospitals Leuven, Leuven, Belgium

    Paul De Munter & Liesbet Henckaerts

  10. Institute for Orthopaedic Research and Training (IORT), KU Leuven, Leuven, Belgium

    Georges Vles & Hazem Wafa

  11. Laboratory of Gene Technology, Department of Biosystems, KU Leuven, Leuven, Belgium

    Rob Lavigne, Stefaan Verwimp & Sabrina Green

  12. Computational Systems Biology, Department of Microbial and Molecular Systems, KU Leuven, Leuven, Belgium

    Stefaan Verwimp & Vera Van Noort

  13. Institute of Biology Leiden, Leiden University, Leiden, The Netherlands

    Vera Van Noort

  14. Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Brussels, Belgium

    Maya Merabishvili & Jean-Paul Pirnay

  15. Interuniversity Institute for Biostatistics (I-BioStat), Hasselt University and KU Leuven, Leuven, Belgium

    Geert Molenberghs

Authors

  1. Laura Bessems
  2. Louise Sykora
  3. Melissa Depypere
  4. Yves Debaveye
  5. Isabel Spriet
  6. David Devolder
  7. Paul De Munter
  8. Liesbet Henckaerts
  9. Georges Vles
  10. Hazem Wafa
  11. Rob Lavigne
  12. Stefaan Verwimp
  13. Vera Van Noort
  14. Sabrina Green
  15. Maya Merabishvili
  16. Jean-Paul Pirnay
  17. Geert Molenberghs
  18. Jolien Onsea
  19. Willem-Jan Metsemakers

Corresponding author

Correspondence to Willem-Jan Metsemakers.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bessems, L., Sykora, L., Depypere, M. et al. Personalized adjunctive phage therapy for difficult-to-treat musculoskeletal infections. Nat Commun (2026). https://doi.org/10.1038/s41467-026-79305-y

Download citation

  • Received: 09 July 2026

  • Accepted: 15 October 2026

  • Published: 05 November 2026

  • DOI: https://doi.org/10.1038/s41467-026-79305-y

来源:Nature 健康护理主题 · nature.com